Skip to main content
Fresenius SE & Co. KGaA logo

Fresenius SE & Co. KGaA — Investor Relations & Filings

Ticker · FRE ISIN · DE0005785604 LEI · XDFJ0CYCOO1FXRFTQS51 F Human health and social work activities
Open in API
Filings indexed 1,398 across all filing types
Latest filing 2007-11-01 Director's Dealing
Country DE Germany
Listing F FRE

About Fresenius SE & Co. KGaA

https://www.fresenius.com/

Fresenius SE & Co. KGaA is a global healthcare company that provides system-critical products and services for leading therapies for the care of critically and chronically ill patients. The company's portfolio encompasses a wide range of products and services for dialysis, hospitals, and outpatient medical care. Key offerings include intravenously administered generic drugs, biopharmaceuticals, biosimilars, clinical nutrition, and infusion therapies. Additionally, the company operates a large network of private hospitals and outpatient centers. Through its strategic investment in Fresenius Medical Care, it is a leading global provider of products and services for individuals with renal diseases.

Recent filings

Filing Released Lang Actions
DGAP-DD: Fresenius SE english
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "Directors’ Dealings" and details a transaction (Purchase) made by a person in a managing body (Stephan Sturm) involving company shares (Fresenius SE Ordinary Shares). This directly corresponds to the definition of Director's Dealing, which maps to the filing code DIRS.
2007-11-01 English
Analyst Meeting - Results Q1-3 2007
Investor Presentation Classification · 98% confidence The document is titled "Analyst Meeting – Results Q1–3/2007" and contains detailed financial tables, segment updates (Fresenius Kabi, ProServe, Medical Care, Biotech), performance metrics (Sales, EBIT, EBIT Margin), and an outlook for 2007. This structure is characteristic of a presentation summarizing periodic financial results and operational performance, typically shared during an investor or analyst event. Since it is a presentation format detailing quarterly results (Q1-3/2007) and includes an agenda and business updates, it strongly aligns with the Investor Presentation (IP) category. It is not a formal regulatory filing like a 10-K or IR, nor is it just a brief earnings release (ER); it is a comprehensive presentation deck.
2007-10-31 English
UBS - Best of Germany Conference, September 2007
Investor Presentation Classification · 98% confidence The document text is titled '# UBS – Best of Germany Conference 2007' and contains sections like 'Safe Habor Statement', 'Fresenius Group: Accomplishments H1 2007', detailed financial tables for H1 2007, segment performance updates (Kabi, ProServe, Biotech), and future outlooks. This structure, presentation format, and focus on recent performance highlights (H1 2007) strongly indicate an Investor Presentation given at a conference, rather than a formal regulatory filing (like 10-K or IR) or a brief earnings release (ER). The content is too detailed for an ER but is structured as a presentation deck, fitting the Investor Presentation (IP) category.
2007-09-12 English
Goldman Sachs - European Medtech & Healthcare Conference, September 2007
Investor Presentation Classification · 98% confidence The document text explicitly states it is a presentation given at the 'Goldman Sachs – European Medtech and Healthcare Services Conference 2007' on September 5/6, 2007. It contains slides summarizing accomplishments for H1 2007, financial results tables, segment performance details, and future outlooks. This structure—a presentation deck used to communicate financial and strategic updates to investors at a conference—is the defining characteristic of an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), but rather a detailed presentation package.
2007-09-05 English
Fresenius SE: Release according to Article 26a, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is very short (1195 characters) and explicitly states it is a 'Total Voting Rights announcement' according to Article 26a of the WpHG. It reports the total number of voting rights as of August 31, 2007. This type of announcement, which reports on the total number of shares/voting rights outstanding, is not explicitly covered by the provided definitions (like DIV, SHA, or POS). Since it is a specific regulatory notification regarding share structure/rights that doesn't fit the primary categories, the most appropriate fallback is the general Regulatory Filings category (RNS). It is not an announcement of a report (RPA) but a direct regulatory disclosure.
2007-08-31 English
Q2 Report 2007
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive quarterly financial report for the Fresenius Group covering the 1st half and 2nd quarter of 2007. It contains detailed financial statements (income statement, balance sheet, cash flow), management discussion and analysis (MDA), segment reporting, and notes. It is clearly a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H2 2007
2007-08-14 German

Browse filings by year

31 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.